After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Medical Instruments & Supplies industry segment, falling under the Healthcare sector. The current market capitalization of DENTSPLY Sirona Inc is $2.49B. A total of 4.2 million shares were traded on the day, compared to an average of 3.66M shares.
In the most recent transaction, LUCIER GREGORY T bought 82,200 shares of XRAY for 11.10 per share on Dec 08 ’25. In a previous transaction on Dec 08 ’25, LUCIER GREGORY T sold 82,200 shares at 11.14 per share. XRAY shares that Director owns now total 0.
Among the insiders who bought shares, VARON LESLIE F acquired of 9,337 shares on Nov 24 ’25 at a per-share price of $10.71. This resulted in the Director holding 57,343 shares of XRAY after the transaction. In another insider transaction, LUCIER GREGORY T bought 15,142 shares at $16.51 per share on Mar 03 ’25. Company shares held by the Director now total 81,971.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, XRAY has a high of $20.59 and a low of $9.85.
As of this writing, XRAY has an earnings estimate of $0.29 per share for the current quarter. EPS was calculated based on a consensus of 16.0 estimates, with a high estimate of $0.44 per share and a lower estimate of $0.25. The company reported an EPS of $0.26 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. XRAY’s latest balance sheet shows that the firm has $339.00M in Cash & Short Term Investments as of fiscal 2021. There were $2.29B in debt and $1.26B in liabilities at the time. Its Book Value Per Share was $7.41, while its Total Shareholder’s Equity was $5.00B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XRAY is Buy with a score of 3.00.
